Slide THE ALPHYN TEAM

OUR PEOPLE

Neal G. Koller

Neal Koller, Chairman & CEO

Neal has been President & CEO and a Director for six life science businesses guiding them to milestone achievement or exit.  He began his career at Wyeth Pharmaceuticals where he achieved notable successes in both large division and early stage business responsibilities.  Neal has over 30 years as a top executive with a successful history of building, running and exiting entrepreneurial and complex global companies.

Neal G. Koller

Neal Koller, Chairman & CEO

Neal has been President & CEO and a Director for six life science businesses guiding them to milestone achievement or exit.  He began his career at Wyeth Pharmaceuticals where he achieved notable successes in both large division and early stage business responsibilities.  Neal has over 30 years as a top executive with a successful history of building, running and exiting entrepreneurial and complex global companies.

Steven Pentelnik

Steven Pentelnik, President

Steven has over 30 years of experience at Procter & Gamble (P&G).  At P&G, he was responsible for its $1 billion early-stage technology portfolio and was a global manager of its $750 million Beauty Care Products business.  Post P&G, he held executive responsibility for developing three start-up companies in medical devices and life sciences.  Steven has a highly successful track-record in bringing new products to market.

Steven Pentelnik

Steven Pentelnik, President

Steven has over 30 years of experience at Procter & Gamble (P&G).  At P&G, he was responsible for its $1 billion early-stage technology portfolio and was a global manager of its $750 million Beauty Care Products business.  Post P&G, he held executive responsibility for developing three start-up companies in medical devices and life sciences.  Steven has a highly successful track-record in bringing new products to market.

Gary Pekoe

Gary Pekoe, PhD, CSO

Gary has his doctorate degree in pharmacology.  He is a thought leader in infectious diseases, skin diseases and cancer.  Gary led the team that developed and obtained FDA approval of Bactroban® (mupirocin), the topical drug of choice for MRSA drug resistant skin infections.  He has directed multiple pharma/biotech product development programs and founded a strategic regulatory and clinical company focused on early stage innovations.  Gary has over 30 years helping develop cutting edge biotechnologies.

Gary Pekoe

Gary Pekoe, PhD, CSO

Gary has his doctorate degree in pharmacology.  He is a thought leader in infectious diseases, skin diseases and cancer.  Gary led the team that developed and obtained FDA approval of Bactroban® (mupirocin), the topical drug of choice for MRSA drug resistant skin infections.  He has directed multiple pharma/biotech product development programs and founded a strategic regulatory and clinical company focused on early stage innovations.  Gary has over 30 years helping develop cutting edge biotechnologies.

Jazmyne Mink

Jazmyne Mink, Scientific Researcher

Jazmyne is a dynamic researcher who has developed a broad understanding of the mechanisms of plant-derived compounds in the treatment of serious skin diseases.

Jazmyne Mink

Jazmyne Mink, Scientific Researcher

Jazmyne is a dynamic researcher who has developed a broad understanding of the mechanisms of plant-derived compounds in the treatment of serious skin diseases.

COMMERCIAL PARTNERS

Grant Services
Grant Services
Laboratory Services
Laboratory Services
Microbiology Services
Microbiology Services
Formulation & Manufacturing
Formulation & Manufacturing
Seed Program, Legal & Patents
Seed Program, Legal & Patents